全文获取类型
收费全文 | 1820748篇 |
免费 | 134163篇 |
国内免费 | 10309篇 |
专业分类
耳鼻咽喉 | 22892篇 |
儿科学 | 57633篇 |
妇产科学 | 48951篇 |
基础医学 | 254098篇 |
口腔科学 | 51313篇 |
临床医学 | 167331篇 |
内科学 | 352646篇 |
皮肤病学 | 40234篇 |
神经病学 | 137366篇 |
特种医学 | 67835篇 |
外国民族医学 | 282篇 |
外科学 | 269675篇 |
综合类 | 57995篇 |
现状与发展 | 24篇 |
一般理论 | 569篇 |
预防医学 | 133883篇 |
眼科学 | 43598篇 |
药学 | 136642篇 |
122篇 | |
中国医学 | 10924篇 |
肿瘤学 | 111207篇 |
出版年
2021年 | 18179篇 |
2019年 | 17180篇 |
2018年 | 23882篇 |
2017年 | 18901篇 |
2016年 | 19914篇 |
2015年 | 24151篇 |
2014年 | 32893篇 |
2013年 | 44884篇 |
2012年 | 62801篇 |
2011年 | 66238篇 |
2010年 | 40269篇 |
2009年 | 36846篇 |
2008年 | 59326篇 |
2007年 | 62560篇 |
2006年 | 62612篇 |
2005年 | 59291篇 |
2004年 | 55651篇 |
2003年 | 52578篇 |
2002年 | 50032篇 |
2001年 | 94083篇 |
2000年 | 95713篇 |
1999年 | 79025篇 |
1998年 | 20976篇 |
1997年 | 18450篇 |
1996年 | 18336篇 |
1995年 | 17642篇 |
1994年 | 16141篇 |
1993年 | 14557篇 |
1992年 | 57995篇 |
1991年 | 55796篇 |
1990年 | 53449篇 |
1989年 | 51141篇 |
1988年 | 46503篇 |
1987年 | 45237篇 |
1986年 | 42467篇 |
1985年 | 40182篇 |
1984年 | 29469篇 |
1983年 | 25024篇 |
1982年 | 13976篇 |
1979年 | 25613篇 |
1978年 | 17644篇 |
1977年 | 14959篇 |
1976年 | 13918篇 |
1975年 | 14595篇 |
1974年 | 17691篇 |
1973年 | 16995篇 |
1972年 | 15730篇 |
1971年 | 14485篇 |
1970年 | 13459篇 |
1969年 | 12536篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
It is hypothesized that persons who use drugs (PWUD) in Vietnam who are also HIV-positive may face additional challenges in psychosocial outcomes, and these challenges may extend to their family members. In this study, we examined depressive symptoms, stigma, social support, and caregiver burden of HIV-positive PWUD and their family members, compared to the outcomes of HIV-negative PWUD and their family members. Baseline, 3-month, and 6-month assessment data were gathered from 83 PWUD and 83 family members recruited from four communes in Phú Th? Province, Vietnam. For PWUD, although we observed a general decline in overall stigma over time for both groups, HIV-positive PWUD consistently reported significantly higher overall stigma for all three periods. Depressive symptoms among family members in both groups declined over time; however, family members of HIV-positive PWUD reported higher depressive symptoms across all three periods. In addition, family members of HIV-positive PWUD reported lower levels of tangible support across all three periods. Caregiver burden among family members of HIV-positive PWUD increased significantly over time, whereas the reported burden among family members of HIV-negative PWUD remained relatively unchanged. The findings highlight the need for future interventions for PWUD and family members, with targeted and culturally specific strategies to focus on the importance of addressing additional stigma experienced by PWUD who are HIV-positive. Such challenges may have direct negative impact on their family members' depressive symptoms, tangible support, and caregiver burden. 相似文献
82.
Toidi Adekambi Chris C. Ibegbu Stephanie Cagle Ameeta S. Kalokhe Yun F. Wang Yijuan Hu Cheryl L. Day Susan M. Ray Jyothi Rengarajan 《The Journal of clinical investigation》2015,125(5):1827-1838
BACKGROUND. The identification and treatment of individuals with tuberculosis (TB) is a global public health priority. Accurate diagnosis of pulmonary active TB (ATB) disease remains challenging and relies on extensive medical evaluation and detection of Mycobacterium tuberculosis (Mtb) in the patient’s sputum. Further, the response to treatment is monitored by sputum culture conversion, which takes several weeks for results. Here, we sought to identify blood-based host biomarkers associated with ATB and hypothesized that immune activation markers on Mtb-specific CD4+ T cells would be associated with Mtb load in vivo and could thus provide a gauge of Mtb infection.METHODS. Using polychromatic flow cytometry, we evaluated the expression of immune activation markers on Mtb-specific CD4+ T cells from individuals with asymptomatic latent Mtb infection (LTBI) and ATB as well as from ATB patients undergoing anti-TB treatment.RESULTS. Frequencies of Mtb-specific IFN-γ+CD4+ T cells that expressed immune activation markers CD38 and HLA-DR as well as intracellular proliferation marker Ki-67 were substantially higher in subjects with ATB compared with those with LTBI. These markers accurately classified ATB and LTBI status, with cutoff values of 18%, 60%, and 5% for CD38+IFN-γ+, HLA-DR+IFN-γ+, and Ki-67+IFN-γ+, respectively, with 100% specificity and greater than 96% sensitivity. These markers also distinguished individuals with untreated ATB from those who had successfully completed anti-TB treatment and correlated with decreasing mycobacterial loads during treatment.CONCLUSION. We have identified host blood-based biomarkers on Mtb-specific CD4+ T cells that discriminate between ATB and LTBI and provide a set of tools for monitoring treatment response and cure.TRIAL REGISTRATION. Registration is not required for observational studies.FUNDING. This study was funded by Emory University, the NIH, and the Yerkes National Primate Center. 相似文献
83.
Jenny U. Johansson Nathaniel S. Woodling Qian Wang Maharshi Panchal Xibin Liang Angel Trueba-Saiz Holden D. Brown Siddhita D. Mhatre Taylor Loui Katrin I. Andreasson 《The Journal of clinical investigation》2015,125(1):350-364
Microglia, the innate immune cells of the CNS, perform critical inflammatory and noninflammatory functions that maintain normal neural function. For example, microglia clear misfolded proteins, elaborate trophic factors, and regulate and terminate toxic inflammation. In Alzheimer’s disease (AD), however, beneficial microglial functions become impaired, accelerating synaptic and neuronal loss. Better understanding of the molecular mechanisms that contribute to microglial dysfunction is an important objective for identifying potential strategies to delay progression to AD. The inflammatory cyclooxygenase/prostaglandin E2 (COX/PGE2) pathway has been implicated in preclinical AD development, both in human epidemiology studies and in transgenic rodent models of AD. Here, we evaluated murine models that recapitulate microglial responses to Aβ peptides and determined that microglia-specific deletion of the gene encoding the PGE2 receptor EP2 restores microglial chemotaxis and Aβ clearance, suppresses toxic inflammation, increases cytoprotective insulin-like growth factor 1 (IGF1) signaling, and prevents synaptic injury and memory deficits. Our findings indicate that EP2 signaling suppresses beneficial microglia functions that falter during AD development and suggest that inhibition of the COX/PGE2/EP2 immune pathway has potential as a strategy to restore healthy microglial function and prevent progression to AD. 相似文献
84.
85.
86.
87.
88.
Implications for Practice
Breast cancer is far more curable than in the past but requires multimodality treatment. Great care must be taken to use the least leukemogenic treatment programs that do not sacrifice efficacy. Elimination of radiation and anthracycline/alkylating agent regimens will be helpful where possible, particularly in younger patients and possibly those with homologous repair deficiency (HRD). Use of colony-stimulating factors should be limited to those who truly require them for safe chemotherapy administration. Further study of a possible leukemogenic association with HRD and the various forms of colony-stimulating factors is badly needed.89.
90.